Oncosil Medical Ltd Capital Reinvestment Ratio
Oncosil Medical Ltd capital reinvestment ratio. Oncosil Medical Ltd (OSL) has a Capital Reinvestment Ratio of 0.07x as of June 2015, meaning it reinvests 0% of its operating cash flow (AU$596.28K) in capital expenditures (AU$43.85K). Check Oncosil Medical Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Oncosil Medical Ltd (2006–2010)
Capital reinvestment ratio of Oncosil Medical Ltd from 2006 to 2010. This chart tracks Oncosil Medical Ltd's Capital Reinvestment Ratio across 2 annual periods. Also explore Oncosil Medical Ltd (OSL) equity growth momentum to track the company's year-over-year net asset growth rate.
Oncosil Medical Ltd Capital Reinvestment Ratio by Year (2006–2010)
Oncosil Medical Ltd capital reinvestment ratio by year from 2006 to 2010. For the full cash flow conversion analysis, see Oncosil Medical Ltd (OSL) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.20x | AU$154.35K | AU$30.48K | ▼ -85.8% |
| 2006 | 1.39x | AU$195.51K | AU$271.11K | — |